CVS Quit Selling Cigarettes, but It’s Found a Patch for Sales
CVS executives knew that some of their sales would go up in smoke when they decided last year to stop selling cigarettes. The press release announcing that all 7,600 CVS stores nationwide would stop selling all tobacco products acknowledged that sales would take a hit. Still, the company said, “This is the right thing to do.”
The costs of the decision are now becoming clear. CVS Health’s general merchandise sales slumped 7.8 percent last quarter on a same-store basis, the company said Tuesday. The company claims non-pharmacy sales would have stayed the same if tobacco sales — and the other products cigarette buyers added to their baskets — were removed from sales figures for the same quarter in 2014.
Related: Why Smoking Is Even Worse Than We Thought
Same-store sales in the pharmacy category climbed 4.1 percent, boosting overall same-store sales growth to 0.5 percent compared with the second quarter of last year, down from a 1.2 percent year-over-year increase the previous quarter. Net revenue overall grew by 7.4 percent to $37.2 billion, helped by pharmacy services revenue that surged 11.9 percent ($2.6 billion) to $24.4 billion. The company has reportedly increased its market share in the health and beauty categories (it did, however, narrow its full-year earnings forecast).
So even as the move to drop cigarettes has cost the company, its bet on health as the source of future growth may be starting to pay off. CVS stock dropped in the wake of its earnings announcement, but shares are still up more than 15 percent on the year and 44 percent over the past 12 months.
Stat of the Day: 0.2%
The New York Times’ Jim Tankersley tweets: “In order to raise enough revenue to start paying down the debt, Trump would need tariffs to be ~4% of GDP. They're currently 0.2%.”
Read Tankersley’s full breakdown of why tariffs won’t come close to eliminating the deficit or paying down the national debt here.
Number of the Day: 44%
The “short-term” health plans the Trump administration is promoting as low-cost alternatives to Obamacare aren’t bound by the Affordable Care Act’s requirement to spend a substantial majority of their premium revenues on medical care. UnitedHealth is the largest seller of short-term plans, according to Axios, which provided this interesting detail on just how profitable this type of insurance can be: “United’s short-term plans paid out 44% of their premium revenues last year for medical care. ACA plans have to pay out at least 80%.”
Number of the Day: 4,229
The Washington Post’s Fact Checkers on Wednesday updated their database of false and misleading claims made by President Trump: “As of day 558, he’s made 4,229 Trumpian claims — an increase of 978 in just two months.”
The tally, which works out to an average of almost 7.6 false or misleading claims a day, includes 432 problematics statements on trade and 336 claims on taxes. “Eighty-eight times, he has made the false assertion that he passed the biggest tax cut in U.S. history,” the Post says.
Number of the Day: $3 Billion
A new analysis by the Department of Health and Human Services finds that Medicare’s prescription drug program could have saved almost $3 billion in 2016 if pharmacies dispensed generic drugs instead of their brand-name counterparts, Axios reports. “But the savings total is inflated a bit, which HHS admits, because it doesn’t include rebates that brand-name drug makers give to [pharmacy benefit managers] and health plans — and PBMs are known to play games with generic drugs to juice their profits.”
Chart of the Day: Public Spending on Job Programs
President Trump announced on Thursday the creation of a National Council for the American Worker, charged with developing “a national strategy for training and retraining workers for high-demand industries,” his daughter Ivanka wrote in The Wall Street Journal. A report from the president’s National Council on Economic Advisers earlier this week made it clear that the U.S. currently spends less public money on job programs than many other developed countries.
